title: Cutaneous metastases secondary to pancreatic cancer.
abstract: OBJECTIVE
  To evaluate prognoses after cutaneous metastases, derived from pancreatic cancer.
  
  
  METHODS
  We treated two patients with cutaneous metastases from pancreatic cancer. We reviewed 40 reported patients in addition to our cases and analyzed clinical features of cutaneous metastases from pancreatic cancer.
  
  
  RESULTS
  The median survival time (MST) was 5 mo after diagnoses of cutaneous metastases. The cumulative 2-year survival rate was 3.5%. The most frequent site of cutaneous metastases was the umbilicus. The MST of patients who were treated with chemotherapy or chemoradiotherapy (CRT) was 6.5 mo, which was statistically longer in comparison to patients without treatment. Prognoses of cutaneous metastases are similar to other metastatic sites from pancreatic cancer. Receiving chemotherapy or CRT was the only prognostic factor of cutaneous metastases from pancreatic cancer.
  
  
  CONCLUSIONS
  The prognoses of cutaneous metastases are similar to other metastatic pancreatic cancers. Receiving chemotherapy or CRT was the only prognostic factor of cutaneous metastases from pancreatic cancer.
authors: Kei Horino, Hiroshi Takamori, Yoshiaki Ikuta, Osamu Nakahara, Akira Chikamoto, Takatoshi Ishiko, Toru Beppu, Hideo Baba, Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
authors: Kei
authors: K
authors: Horino
authors: Hiroshi
authors: H
authors: Takamori
authors: Yoshiaki
authors: Y
authors: Ikuta
authors: Osamu
authors: O
authors: Nakahara
authors: Akira
authors: A
authors: Chikamoto
authors: Takatoshi
authors: T
authors: Ishiko
authors: Toru
authors: T
authors: Beppu
authors: Hideo
authors: H
authors: Baba